Delivery Order SPE2DB22D2007-SPE2DB25FJ0CD

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,975.98, is for the delivery of RYTARY ER 48.75 MG-195 MG capsules. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a wide range of pharmaceutical products and...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,966.05, is for the delivery of RYTARY ER 48.75 MG-195 MG capsules. The award is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award, valued at $11,748.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 36.25 MG-145 MG capsules, a prescription medication. The award is a delivery order against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $1,741.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 23.75 MG-95 MG CAP 100S, a prescription medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $5,289.56 and covers the supply of RYTARY ER 36.25 MG-145 MG capsules, a prescription medication, with a period of performance through March 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,464.21, is for the delivery of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type. It was awarded on March 19, 2025 with an ultimate completion date of March 20, 2025. The contract does not have a set-aside...
This is a $5,199.22 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RYTARY ER 36.25 MG-145 MG capsules. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, with a ceiling value of $6,625.52 and a delivery completion date of November 7, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,196.87, is a Firm Fixed Price Delivery Order for the supply of RYTARY ER 48.75 MG-195 MG capsules. The contract has an ultimate completion date of June 7, 2024 and was awarded on June 6, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,018.34 firm-fixed-price delivery order contract, with a completion date of May 6, 2024, is for the supply of RYTARY ER 61.25 MG-245 MG capsules. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ0CD
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,073.30, is for the delivery of RYTARY ER 23.75 MG-95 MG capsules. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is March 24, 2025.

The contract award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and sole awardee on this contract. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/21/25, 9:53 AM